drugset / Trial / NCT06531538
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to learn about the safety, tolerability and immune effects of a pneumococcal vaccine in toddlers. Participants will take part in this study for approximately 6 or 8 months depending on which group they are assigned to. During this time participants will have 2 clinic visits and 1 phone visit for the 1-Dose group, or 3 clinic visits and 1 phone visit for the 2-Dose group. At these clinic visits, participants will be asked if any side effects were experienced. The participants will also have to give blood samples during some clinic visits.
Timeline
- Start
- 2024-07-30
- Primary completion
- 2026-02-09
- Completion
- 2026-02-09